Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Short term Debt (2018 - 2025)

Historic Short term Debt for Veracyte (VCYT) over the last 9 years, with Q3 2025 value amounting to $13.6 million.

  • Veracyte's Short term Debt rose 8361.52% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 8361.52%. This contributed to the annual value of $17.0 million for FY2024, which is 53910.43% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Short term Debt is $13.6 million, which was up 8361.52% from $13.4 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Short term Debt peaked at $17.0 million during Q4 2024, and registered a low of $2.6 million during Q3 2023.
  • Its 5-year average for Short term Debt is $6.7 million, with a median of $6.0 million in 2021.
  • As far as peak fluctuations go, Veracyte's Short term Debt crashed by 5646.88% in 2023, and later soared by 53910.43% in 2024.
  • Veracyte's Short term Debt (Quarter) stood at $2.7 million in 2021, then surged by 125.95% to $6.1 million in 2022, then plummeted by 56.16% to $2.7 million in 2023, then skyrocketed by 539.1% to $17.0 million in 2024, then fell by 20.08% to $13.6 million in 2025.
  • Its Short term Debt stands at $13.6 million for Q3 2025, versus $13.4 million for Q2 2025 and $14.4 million for Q1 2025.